Nearly one in five American adults are living with a mental illness today. This fact highlights an urgent need for better mental health resources and support systems. With this need in mind… Read More

Feeling Anxiety is very normal in human life. Anxiety affects everyone in a very different manner. 3 out of 10 adults in the United States suffer from depression and 19.1% of adults in the A… Read More

Image source: The Motley Fool. Axsome Therapeutics (AXSM -0.64%)Q3 2023 Earnings CallNov 06, 2023, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepa… Read More

Dementia can be a terrifying health issue, and this is a threat not only to the elderly these days. Check out the latest amazing reports about how you can defy this terrible nightmare. Defyi… Read More

In the dynamic sphere of mental health solutions, Auvelity emerges as a noteworthy advancement in psychiatric medication. Paving the way for improved mental health, this groundbreaking treat… Read More

Major Depressive Disorder (MDD) is one of the serious mental health conditions that can have significant impacts on individuals’ well-being and quality of life. While it is important t… Read More

Major Depressive Disorder (MDD), also known as depression, is a significant and widespread mental health condition that affects millions of people worldwide. Understanding the intricacies of… Read More

It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with MDD diagnoses and the unmet d… Read More

Source: Streetwise Reports  (10/11/22) Asset manager Chen Lin’s picks for the home stretch of 2022 include several biotechs and some precious metals companies. Asset manager… Read More

In this episode, Ayesha discussed the FDA approval of Axsome Therapeutics’ rapid-acting oral treatment Auvelity for the treatment of major depressive disorder (MDD). The approval makes… Read More